Senior Director, Head of Multi-Omics Discovery
Publication date:
03 October 2024Workload:
100%Contract type:
Permanent position- Place of work:Beerse
Johnson & Johnson s recruiting for a Senior Director, Head of Multi-Omics Discovery, located in either Spring House, PA, Boton, MA or Beerse, Belgium.
The Senior Director will report to the Vice President of DTMP and will be responsible for leading and executing a comprehensive 3-year plan to support the Discovery portfolio across multiple therapeutic areas and modalities, utilizing advanced Omics technology platforms, including Functional Genomics, Transcriptomics, and Proteomics. A key focus will be on building strong partnerships with Therapeutic Area leaders to develop and reshape target biology strategies. This role will accelerate drug discovery timelines by applying high-dimensional biology and multi-omics platforms to efficiently generate and validate hypotheses, rapidly identify potential drug candidates, and uncover novel biomarkers that signal disease progression and treatment response. The Senior Director will also drive a paradigm shift from traditional target selection to New Molecular Entity (NME) nomination, leveraging integrated high-dimensional biology platforms to model cellular pathways in both healthy and disease states.
This role will require the ability to assess a large number of drug targets simultaneously within complex cellular models, using genetic and proteomics readouts to predict liability, differentiate modalities, and connect underlying mechanisms from phenotype to gene in patient samples. The Senior Director will guide Discovery projects in interpreting and utilizing high-dimensional biology data to inform decisions. Additionally, they will be responsible for building an end-to-end process that applies integrated omics platforms at scale, enabling faster hypothesis generation, validation, and translatability across programs.
The Senior Director will also play a critical role in identifying and validating combination strategies for Immunology (IMM) and Oncology (Onc) programs, increasing the throughput of single-cell technologies and data analytics to advance immune cell phenotyping, and driving co-stimulatory molecule research and T-cell therapies. They will lead efforts in next-generation RNA sequencing (RNAseq) and proteomics for target discovery, validation, and biosignature development across multiple modalities, enabling progress on difficult target classes. This leadership position will ensure the delivery of comprehensive data packages to assess target progression and risk, driving innovation and efficiency in the drug discovery process.
Major Duties & Responsibilities include but are not limited to:
Coordinate project needs and timeline and deliverables and resource distribution across portfolio and across sites
Address cutting-edge and scalability needs to support therapeutic discovery and optimization
Drive team efficiency and rapid data turn around time to impact portfolio
Develop and execute partnerships with leaders across competitive landscape and partners
Participate in DTMP strategy development and future function upgrade and lean process/concept launch and Lead Bluewater project